Pharmacogenomic personalised medicine for antiplatelet agents is on the horizonBMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e4198 (Published 19 June 2012) Cite this as: BMJ 2012;344:e4198
- Christopher N Floyd, clinical research fellow1
- 1King’s College London, London, UK
Kitsios and Kent’s article on pharmacogenomics states that no trials have examined a “test and treat” strategy when prescribing clopidogrel.1 Recently, however, Roberts and colleagues used such an approach when prescribing dual …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial